CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 901024039
- Phone
- 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- NT 10-K Other NT 10-K
- 8-K Event Agreement ended · Regulation FD disclosure
- 8-K Event Delisting notice
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Results of operations · Other events
- 8-K Event Executive or director change
- 8-K Event Other events
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 144 Insider Sale of Securities
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 4 of 24 · 467 filings